Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

PKCζ (113-125) (myristoylated)

PKC inhibitor
 
BML-P219-0500 0.5 mg 154.00 USD
Do you need bulk/larger quantities?
 
Pseudosubstrate sequence from human PKCζ (113-125) completely conserved in rabbit, rat, mouse and Xenopus. Sequence is also identical in human PKCι; (114-126) and mouse PKCλ. The N-terminus is myristoylated to allow cell permeability. Peptide inhibitor of atypical PKC’s (calcium/phorbol ester/diacyglycerol insensitive). Useful in conjunction with the Myristoylated PKC (20-28), Cell-permeable PKC Inhibitor (BML-P205).

Product Details

Alternative Name:Protein kinase C ζ (113-125) (myristoylated), PKCζ pseudosubstrate
 
Sequence:N-Myristoyl-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu-OH
 
Formula:C90H154N30O17
 
MW:1928.2
 
Formulation:Lyophilized.
 
Purity:≥97% (HPLC)
 
Solubility:Soluble in water or DMSO.
 
Shipping:Blue Ice
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 

Product Literature References

Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids: A. Khalifeh-Soltani, et al.; Nat. Med. 20, 175 (2014), Abstract; Full Text

Product Toolbox

PRODUCT RESOURCES

Datasheet
SDS
Certificate of Analysis

RELATED PRODUCTS

By target:
PKC
By biological activity:
PKC Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service